SUMMIT SURGICAL LLC — History
CCN 170198 | 3-year financial timeline | COVID resilience: 68/100
🛡️ Public data only — no PHI permitted on this instance.
$13M
Latest Revenue (FY2022)
+22.5%
Revenue CAGR (3yr)
5.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $9M | $11M | $13M | +24.2% | +22.5% |
| Operating Expenses | $8M | $10M | $12M | +21.0% | +21.9% |
| Operating Margin | 4.4% | 2.7% | 5.2% | +93.5% | +9.0% |
| Net Income | $0M | $0M | $1M | +140.3% | +33.4% |
| Licensed Beds | 10 | 10 | 10 | +0.0% | +0.0% |
| Total Patient Days | 781 | 682 | 892 | +30.8% | +6.9% |
| Medicare Day % | 46% | 39% | 40% | +2.4% | -6.6% |
| Medicaid Day % | 2% | 2% | 0% | -72.2% | -57.1% |
COVID Impact & Recovery
Resilience Score: 68/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +50.0% ($9M → $13M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+22.5%
This Hospital
+7.6%
State Avg
Latest Margin
5.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $15M | 5.7% |
| FY2024 (proj) | $17M | 6.1% |
| FY2025 (proj) | $20M | 6.5% |